Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FS6LP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,415
Award facts
- Contract value 100% obligated
- $51,414.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $51,414.56 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. This competitive award, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. Cosentyx is a biologic immunosuppressant used to treat various autoimmune and inflammatory conditions, reflecting the Defense Health Agency's ongoing procurement of specialized pharmaceutical products to support military healthcare programs.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of medical supply deliveries predominantly through DLA Medical Supply Chain contracts. The company's federal procurement history demonstrates consistent capability to deliver diverse therapeutic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems on a global scale.
Quick answers
Who was awarded contract SPE2DB25FS6LP?
SPE2DB25FS6LP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FS6LP worth?
The government has obligated $51,415 on SPE2DB25FS6LP.
Is contract SPE2DB25FS6LP an order under another contract?
Yes. SPE2DB25FS6LP is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6LP competed?
The extent of competition for SPE2DB25FS6LP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award